ASN and AAKP Advocates Urged Congress to Support KidneyX

By ASN Staff

Founded in 2018, KidneyX is a patient centered solution designed to reduce the specific barriers that hinder innovation in the prevention, diagnosis, and treatment of kidney diseases, and catalyze private sector involvement in ways that are not currently addressed by the public and private sectors. KidneyX will initially focus on the development and commercialization of next-generation dialysis products, and will later expand to include diagnostics, other devices, medications, and patient-centered tools to more effectively and efficiently manage kidney diseases.

Advocates from the American Society of Nephrology (ASN) and the American Association of Kidney Patients (AAKP) met with representatives, senators, and their respective staffs on March 28, 2018 to urge Congress to support KidneyX, a new public-private partnership to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.

“The prevalence of kidney diseases in the U.S. is at a record high,” said Crystal A. Gadegbeku, MD, chair of the ASN Policy and Advocacy Committee. “To improve the lives of millions of Americans, we need Congress to support KidneyX and the commercialization of promising innovations for people with kidney diseases. The Government Accountability Office (GAO) report highlighting the burden of kidney diseases in America is a wake-up call and KidneyX offers a pathway that will potentially help us better serve Americans.”

Please read the full press release.

Category:
Subcategory:
Author:
ASN Staff
Article Image:
Body:

Founded in 2018, KidneyX is a patient centered solution designed to reduce the specific barriers that hinder innovation in the prevention, diagnosis, and treatment of kidney diseases, and catalyze private sector involvement in ways that are not currently addressed by the public and private sectors. KidneyX will initially focus on the development and commercialization of next-generation dialysis products, and will later expand to include diagnostics, other devices, medications, and patient-centered tools to more effectively and efficiently manage kidney diseases.

Advocates from the American Society of Nephrology (ASN) and the American Association of Kidney Patients (AAKP) met with representatives, senators, and their respective staffs on March 28, 2018 to urge Congress to support KidneyX, a new public-private partnership to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.

“The prevalence of kidney diseases in the U.S. is at a record high,” said Crystal A. Gadegbeku, MD, chair of the ASN Policy and Advocacy Committee. “To improve the lives of millions of Americans, we need Congress to support KidneyX and the commercialization of promising innovations for people with kidney diseases. The Government Accountability Office (GAO) report highlighting the burden of kidney diseases in America is a wake-up call and KidneyX offers a pathway that will potentially help us better serve Americans.”

Please read the full press release.

Area(s) of Interest:
Date:
Tuesday, April 3, 2018